Release Date: 26/06/18 18:18 Summary: Resignation of Director and Appendix 03Z Price Sensitive: No Download Document 401.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%